403 related articles for article (PubMed ID: 10454487)
21. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
22. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
23. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
Butelman ER; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
[TBL] [Abstract][Full Text] [Related]
24. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
25. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
Cook CD; Nickerson MD
J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
Gerak LR; Butelman ER; Woods JH; France CP
J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
[TBL] [Abstract][Full Text] [Related]
27. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
[TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
29. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
[TBL] [Abstract][Full Text] [Related]
30. Qualitative sex differences in kappa-opioid analgesia in mice are dependent on age.
Sternberg WF; Ritchie J; Mogil JS
Neurosci Lett; 2004 Jun; 363(2):178-81. PubMed ID: 15172110
[TBL] [Abstract][Full Text] [Related]
31. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
[TBL] [Abstract][Full Text] [Related]
32. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
Fischer BD; Dykstra LA
J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
[TBL] [Abstract][Full Text] [Related]
33. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
35. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
[TBL] [Abstract][Full Text] [Related]
36. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.
Millan MJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):334-41. PubMed ID: 2571722
[TBL] [Abstract][Full Text] [Related]
37. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
38. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
39. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats.
Terner JM; Barrett AC; Grossell E; Picker MJ
Psychopharmacology (Berl); 2002 Sep; 163(2):183-93. PubMed ID: 12202965
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber).
Towett PK; Kanui TI; Juma FD
Brain Res Bull; 2006 Dec; 71(1-3):60-8. PubMed ID: 17113929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
